Looking Into NeuroOne Medical Tech's Return On Capital Employed NeuroOne Medical Tech (NASDAQ:NMTC) brought in sales totaling $33.75 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 6.22%, resulting in a loss of $2.81 million. Benzinga · Feb 15, 2022